TABLE 3.

Adverse drug events related to sprionolactone therapy

Side Effect	Dinsdale et al. N =64	Butler et al. N =18	RALES N =1663
Hyperkalemia >5.5 mmol/L	36%	33%	2%
Acute Kidney Injury	37.5%	0	Not Reported
Discontinuation	34%	0	8%